MSB 1.95% $1.05 mesoblast limited

CHF Accelerated Approval !, page-120

  1. 495 Posts.
    lightbulb Created with Sketch. 47
    I found this one on google search. Looks like published on 22nd March.

    Link

    Lumbar Degenerative Disc Disease Market is Expected To Grow During The Forecast Period (2019-2032) DelveInsight | Key Players – Mesoblast and Gruenthal, DiscGenics, and Others



    Read more: https://www.digitaljournal.com/pr/lumbar-degenerative-disc-disease-market-is-expected-to-grow-during-the-forecast-period-2019-2032-delveinsight-key-players-mesoblast-and-gruenthal-discgenics-and-others#ixzz7OOyGGmN2




 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.05
Change
0.020(1.95%)
Mkt cap ! $1.193B
Open High Low Value Volume
$1.02 $1.07 $1.02 $7.487M 7.196M

Buyers (Bids)

No. Vol. Price($)
4 39700 $1.05
 

Sellers (Offers)

Price($) Vol. No.
$1.05 86509 6
View Market Depth
Last trade - 16.10pm 07/06/2024 (20 minute delay) ?
Last
$1.05
  Change
0.020 ( 1.89 %)
Open High Low Volume
$1.02 $1.07 $1.02 1379563
Last updated 15.59pm 07/06/2024 ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.